NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Chong Kun Dang Pharmaceutical (KO: 185750)
185750 Technical Analysis
2
As on 20th Dec 2024 185750 STOCK Price closed @ 90700.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 102754.03 & Strong Buy for SHORT-TERM with Stoploss of 81703.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
185750STOCK Price
Open | 90900.00 | Change | Price | % |
High | 91800.00 | 1 Day | -700.00 | -0.77 |
Low | 90000.00 | 1 Week | 800.00 | 0.89 |
Close | 90700.00 | 1 Month | -13900.00 | -13.29 |
Volume | 27956 | 1 Year | 6800.00 | 8.10 |
52 Week High 133599.88 | 52 Week Low 73999.93 |
KO Korea Most Active Stocks
008350 | 1700.00 | 19.72% |
008350 | 1700.00 | 19.72% |
096300 | 156.00 | -6.02% |
096300 | 156.00 | -6.02% |
168490 | 159.00 | 29.27% |
168490 | 159.00 | 29.27% |
009270 | 1500.00 | 5.26% |
009270 | 1500.00 | 5.26% |
001380 | 4210.00 | -9.75% |
001380 | 4210.00 | -9.75% |
KO Korea Top Gainers Stocks
KO Korea Top Losers Stocks
185750 Daily Charts |
185750 Intraday Charts |
Whats New @ Bazaartrend |
185750 Free Analysis |
|
185750 Important Levels Intraday
RESISTANCE | 94168.60 |
RESISTANCE | 93056.20 |
RESISTANCE | 92368.60 |
RESISTANCE | 91681.00 |
SUPPORT | 89719.00 |
SUPPORT | 89031.40 |
SUPPORT | 88343.80 |
SUPPORT | 87231.40 |
185750 Forecast December 2024
4th UP Forecast | 119412 |
3rd UP Forecast | 110204 |
2nd UP Forecast | 104512 |
1st UP Forecast | 98820.5 |
1st DOWN Forecast | 82579.5 |
2nd DOWN Forecast | 76887.7 |
3rd DOWN Forecast | 71195.9 |
4th DOWN Forecast | 61987.7 |
185750 Weekly Forecast
4th UP Forecast | 100335.00 |
3rd UP Forecast | 97245.00 |
2nd UP Forecast | 95335.00 |
1st UP Forecast | 93425.00 |
1st DOWN Forecast | 87975.00 |
2nd DOWN Forecast | 86065.00 |
3rd DOWN Forecast | 84155.00 |
4th DOWN Forecast | 81065.00 |
185750 Forecast2024
4th UP Forecast | 219616 |
3rd UP Forecast | 178272 |
2nd UP Forecast | 152716 |
1st UP Forecast | 127160 |
1st DOWN Forecast | 54239.5 |
2nd DOWN Forecast | 28683.8 |
3rd DOWN Forecast | 3127.99 |
4th DOWN Forecast | -38216.2 |
Chong Kun Dang Pharmaceutical ( KO Korea Symbol : 185750 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
185750 Other Details
Segment | EQ | |
Market Capital | 1338773864448.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
185750 Address
185750 Latest News
185750 Business Profile
Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea. Address: 8, Chungjeong-ro, Seoul, South Korea
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service